Furthermore, according to recent reports, LAM patient plasma showed increased IL‐6 relative to healthy controls, and IL‐6 blockade inhibited the proliferation and migration of TSC2‐deficient cells.57 Here, IL6 is linked to lymphangioleiomyomatosis.